Apteka Eskulap Spj. D. I R. Gargolsp. j. in liquidation
Retail sale of pharmaceutical goods
Overview
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 4 of 6 financial statements were filed late (the longest delay 914 days for 2020), 1 not filed.
- 2025not filed
- 202422/09/2025
- 202316/04/2024
- 202216/04/2024
- 202116/04/2024
- 202016/04/2024
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Results vs industry
Industry
National Health Fund (NFZ) contracts
Apteka Eskulap Spj. D. I R. Gargol has been an NFZ healthcare provider since 2008. In 2023 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 0.00 in total.
NFZ contract value by year (USD)
| Type of care | NFZ branch | Contracts | Value in 2023 |
|---|---|---|---|
| Provision of medical devices | lubelskie | 1 | USD 0.00 |
Authorized Representatives
Ownership
| Owner |
|---|
Ryszard Zbigniew Gargolage 71 |
Artur Kosiorowskiage 67 |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 1995-09-18 to 2026-05-13.
Reason for removal: Art. 96 ust. 9a pkt 3 (VAT returns showing no transactions filed for 6 consecutive months or 2 quarters)
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $26,707.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 11, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Polski Fundusz Rozwoju S.A. |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Eurotter LogistykaS.K.A. | $8,828,819.87 | eurotter.com.pl | ||
| Transtrade Polskasp. z o.o. | $5,469,317.54 | transtradebrest.com | ||
| SFFsp. z o.o. | $3,425,286.50 | solutionff.com | ||
| GPW LogisticsS.A. | $3,037,167.25 | gpwlogistics.pl | ||
| Camel Spedsp. z o.o. | $2,731,925.77 | camelsped.pl | ||
| Extreme Transsp. z o.o. | $1,686,899.18 | extreme-trans.pl | ||
| Senvilosp. z o.o. | $1,228,175.20 | senvilo.com | ||
| Maeysp. z o.o. | $38,984.64 | maey.eu | ||
| Bomar Prosp. z o.o. | $16,355.27 | bomar-transport.pl | ||
| TRG Logisticsp. z o.o. | $2.51 | trglogistic.pl |
Change history
| Date | Event | |
|---|---|---|
| 2023-03-30 | Name change (Apteka "eskulap" Spj. D. I R. Gargol → Apteka "eskulap" Spj. D. I R. Gargol W Likwidacji) | |
| 2017-12-15 | Liquidation opened | |
| 2001-04-03 | Entered in the register |
FAQ
Last updated: 2026-08-30